Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib may effectively treat nail changes in alopecia areata.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Radiological findings help distinguish LAM, PLCH, and BHD to avoid invasive tests.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The study concluded that Acral lick dermatitis is most common in young male Labrador retrievers, often caused by psychological factors, and leads to skin inflammation and stress-related blood changes.

Low-level laser therapy is a safe and effective treatment for hair loss.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Alopecia Areata might be linked to Crohn's disease.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Red light therapy at 655 nm significantly improved hair growth in men with hair loss.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Abatacept may help some people with alopecia areata regrow hair.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Low-level light therapy can safely and effectively stimulate hair growth in people with androgenetic alopecia.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.